FDA offers paperless drug registration

WASHINGTON The Food and Drug Administration launched a new program yesterday aimed at allowing manufacturers to electronically file drug establishment registration and drug listing information, such as ingredients, labeling and manufacturing information.

The program marks the first time electronic filing will be available for all manufacturers of human drug products, including over-the-counter and biological drug products, as well as veterinary drugs.

The agency intends on ending the transition period and only accept electronic files for drug establishment registration and drug listing beginning on June 1, 2009.